Edward Borkowski - Jul 1, 2021 Form 4 Insider Report for TherapeuticsMD, Inc. (TXMD)

Signature
/s/ Edward Borkowski
Stock symbol
TXMD
Transactions as of
Jul 1, 2021
Transactions value $
$0
Form type
4
Date filed
7/2/2021, 05:51 PM
Previous filing
May 12, 2021
Next filing
Jan 3, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TXMD Performance Stock Units Award $0 +373K $0.00 373K Jul 1, 2021 Common Stock 373K $0.00 Direct F1
transaction TXMD Restricted Stock Units Award $0 +187K $0.00 187K Jul 1, 2021 Common Stock 187K $0.00 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One half of the performance stock units (PSUs) vest based on the issuer achieving certain revenue milestones over the period from 2021 through 2023, and one half of the PSUs vest based on the issuer achieving certain earnings before interest, taxes, depreciation and amortization (EBITDA) milestones no later than December 31, 2023. In the event that any of the foregoing are not achieved, the corresponding portion of the PSUs will be forfeited. The number of PSUs listed is the base number of PSUs that may vest. The actual number of PSUs that will vest will be between zero and two times the base number of PSUs depending on the milestones achieved. In accordance with the terms of the issuer's 2019 Stock Incentive Plan, no PSUs will vest prior to the one-year anniversary of the grant date. Each PSU represents a contingent right to receive one share of common stock of the issuer.
F2 Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock of the issuer. The RSUs will vest in three equal installments annually beginning July 1, 2022, becoming fully vested on July 1, 2024.